Industry & Business
Off-Topic Submission: No Functional Ingredient News Found
Submission flagged: content does not meet Functional News editorial scope. No ingredient, clinical data, regulatory fil…
All 681 stories
Ingredients & Formulation
Intravacc Expands Analytical Services for Biologics Development
As biologics complexity grows, contract development organizations are investing in end-to-end analytical infrastructure…
Regulatory & Policy
Canadian Pesticide Bill Sparks Industry-Wide Regulatory Concern
Proposed legislative changes could reshape ingredient safety frameworks with downstream implications for nutraceutical …
Condition-Specific Health
Brainwell Institute, ASO Launch Ontario Dementia Care Task Force
The policy initiative signals growing institutional demand for research-backed brain health solutions — a tailwind for …
Industry & Business
Out-of-Scope Submission: No Functional Food Content Found
Submission concerns a healthcare finance executive award — outside Functional News editorial scope.
Science & Research
GT Biopharma TriKE Platform Moves Three Oncology Candidates to Clinic
The NK-cell engager approach sits outside core nutraceutical channels, but biotech-to-ingredient crossover investors ar…
Ingredients & Formulation
Intravacc Touts Integrated Analytics Platform for Biologics Dev
As biologics complexity grows, contract development organizations are positioning end-to-end analytical services as a c…
Condition-Specific Health
Chronic Pain Research Gap in Women Signals Formulation Opportunity
Pan-Canadian strategy roadmap identifies research and care gaps — opening a lane for evidence-backed nutraceutical and …
Condition-Specific Health
Chronic Pain Gap in Women and Veterans Signals Formulation Opportunity
Pan-Canadian strategy roadmap identifies research, care, and policy gaps — opening space for evidence-backed nutraceuti…
Condition-Specific Health
Gildeuretinol Enters Phase 3 Trial for Stargardt Disease
The deuterium-stabilized vitamin A analog moves into global pivotal testing, raising questions about regulatory classif…
Condition-Specific Health
Neridronate Enters Phase 3 Trial for Rare Pain Condition CRPS-1
With an estimated 65,000 new U.S. cases annually, CRPS-1 represents a significant unmet need that could open upstream i…
Ingredients & Formulation
Koi Peptides Expands Research Catalog With HPLC-Verified Reference Compounds
The expansion targets analytical and preclinical research settings — not finished formulations or consumer supplementat…